Patrick M. Sweeney & Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$547K Sell
6,994
-260
-4% -$21K 0.31% 81
2026
Q1
$629K Sell
7,254
-10
-0.1% -$958 0.4% 64
2025
Q4
$698K Buy
7,264
+30
+0.4% +$2.91K 0.44% 60
2025
Q3
$689K Buy
7,234
+80
+1% +$7.35K 0.45% 56
2025
Q2
$632K Buy
7,154
+200
+3% +$17K 0.44% 59
2025
Q1
$625K Hold
6,954
0.47% 54
2024
Q4
$555K Buy
6,954
+455
+7% +$39.4K 0.42% 65
2024
Q3
$585K Buy
6,499
+444
+7% +$37.4K 0.43% 62
2024
Q2
$477K Buy
6,055
+305
+5% +$25K 0.39% 69
2024
Q1
$511K Buy
5,750
+125
+2% +$10.7K 0.42% 64
2023
Q4
$463K Buy
+5,625
New +$429K 0.42% 62

Other funds holding MDT

Patrick M. Sweeney & Associates's MDT Position: Q2 2026 in Review

Patrick M. Sweeney & Associates reduced its Medtronic (MDT) stake by 3.6% in Q2 2026, selling an estimated $21K and leaving 6,994 shares worth $547K. The position accounts for 0.31% of the portfolio, ranked #81.

Patrick M. Sweeney & Associates first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $698K in Q4 2025. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Patrick M. Sweeney & Associates held 6,994 shares of Medtronic worth $547K as of Q2 2026.
  • Patrick M. Sweeney & Associates sold 260 Medtronic shares in Q2 2026, an estimated $21K.
  • Medtronic made up 0.31% of Patrick M. Sweeney & Associates's portfolio in Q2 2026, its #81 holding.
  • Patrick M. Sweeney & Associates first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Patrick M. Sweeney & Associates's Medtronic position peaked at $698K in Q4 2025.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.